Friday, December 12, 2014 6:10:46 AM
And I am also a reasonable PPHM investor and no day or swing trader. Let's go over some of the PPHM BoD memebers:
CEO S. King:
Knowledgeable about the lab (Avid), pupil of Doctor Thrope and co-patent inventor of some of PPHM's Key-Patents, friend of Dr. Brekken who heads the new joint labs Brekken+Thrope, and a CEO of PPHM since many years after having occupied other functions before and after the TCLN merging. Managed to surround himself with a TOP team of managers, employees and consultants and attracted TOP Key Opinion Leaders. If said that he was not experienced, then now, after all those years as PPHM CEO he must have acquired it. Some will say that we paid for it, well fine, I am glad we did because he didn't run away and works hard. He did his day job at night and that might even have costed him his marriage.
BoD Member Eric Swartz:
Well invested in PPHM stock and saved the company with his own funds when PPHM was at a point where bankruptcy wasn't just an idle PPHM IHUB doom-word. Has never done anything that harms PPHM but yet is often criticized because in his past he had jobs in which he had to work with off-shore companies. And as a consequence, and by definition, he is not good because of that according some. Well I think that if you are loaded with stock as he is then concentrating only on PPHM probably might catapult him within a reasonable time frame at the level of US Top 100 richest people. Why would he put that at risk?
BoD Chairman Carlton Johnson:
Now that guy seems not to be able to do anything good in the eyes of some. Even if he says we go to the bottom of things in the PPHM annual meeting held in 2012 after the dose switching/now sabotage incident (which is exactly what PPHM did with its investigation). Next one holds timing against him; we didn't go sufficiently fast to the bottom of it. But the man's name surfaces most in combination with words like DIOS and Statson and sometimes he is written into the role of BoD member of other companies even if that is not the case any more since long. Now, I cannot say that he is a Saint but unless we know EXACTLY who did what behind the curtains in both mentioned cases I really don't see why the manure should be shuffled into his shoes.
BoD Member David Pohl
An attorney with experience of BoD positions of public companies and a very clean and well document professional history. You need someone like him in a BoD. But since there isn't much manure in his curriculum lets just accuse him from being one of the lap-dogs of ES to keep the majority vote in PPHM's BoD. We absolutely need to do that because otherwise he could be qualified as a good guy and we cannot let that happen, can we!
But let it be THAT it is EXACTLY THAT that is my MAJOR reason for liking the BoD composition of 4 with at least one cluster of 3 (and I actually think King is probably #4 if he is smart) that will for sure not give away PPHM easily. PPHM at this point has a good CEO with a GREAT team of people that are making it happen.
So the ONLY thing I expect from the BoD (really the ONLY thing) is that they do that ONE thing they CAN and that the CEO and his great team CANNOT! And that is to GUARD THE POISON PILL.
PPHM is a very attractive, and market cap wise EASY, target for hostile acquisition. This is even more true now that they have near 70Milj$ on the bank, no creditors and fully and unencumbered own and control their pipelines and related IP. This pipeline contains Bavituximab, very possibly the drug that will make Peregrine Pharmaceuticals the Microsoft of Biotechnology. And lately, even two days ago at the quarterly, we start to more and more see the signs that it is going that way, no matter the current PPHM PPS that is becoming the only argument left against the company (but watch the coming period).
The POISON PILL is the ONLY thing that keeps us form seeing that huge (and daily increasing) potential of BAVITUXIMAB been given away or hi-jacked for breadcrumbs (while WE ALL financed it, which would make us bag-holders). If we want LEVERAGE through the PPHM common shares then we need a BoD, Management and employees that all have the SAME INCENTIVE through owning cheap options up to and including hard PPHM stock.
The BoD is the ONLY instance that can TRIGGER the poison pill because it is NOT something that automatically triggers on a poor offer to shareholders. So you depend on a MAJORITY in the BoD to trigger it. And this BoD has that majority, of any other I am not sure we can say that with the same certainty.
I may not be able to tell you much more about the depths of thought of the BoD members but there is ONE SINGLE thing I am sure OFF! They will trigger the poison pill in case of an unreasonable proposition to the shareholders. And that is really ALL I expect from them. If they do that they served there goal in making PPHM big. And is is SK himself that has several times now hinted at the astronomical value and potential of Bavituximab, so it is not that they could claim that they didn't know what it is worth!
But I am glad we at least all agree that bavituximab is the drug with the huge potential. It has been different in the past where it was called a placebo or was said to never make it in a PIII clinical trial. Now it is the BoD that is no good and when they score big time it will be something else. Let's concentrate on SUNRISE for now. That is what those people that work for PPHM on a daily basis are doing.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.
Recent CDMO News
- Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. • PR Newswire (US) • 11/07/2024 10:55:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:59:47 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:42:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 02:11:21 AM
- Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction • GlobeNewswire Inc. • 11/06/2024 11:04:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM